Home
>
National Drug Code (NDC)
>
Eliphos
Eliphos - 63717-910-02 - (Calcium Acetate)
Drug Information of Eliphos
| Product NDC: | 63717-910 |
| Proprietary Name: | Eliphos |
| Non Proprietary Name: | Calcium Acetate |
| Active Ingredient(s): | 667 mg/1 & nbsp; Calcium Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Eliphos
| Product NDC: | 63717-910 |
| Labeler Name: | Hawthorn Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078502 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090201 |
Package Information of Eliphos
| Package NDC: | 63717-910-02 |
| Package Description: | 200 TABLET in 1 BOTTLE (63717-910-02) |
NDC Information of Eliphos
| NDC Code | 63717-910-02 |
| Proprietary Name | Eliphos |
| Package Description | 200 TABLET in 1 BOTTLE (63717-910-02) |
| Product NDC | 63717-910 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Calcium Acetate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090201 |
| Marketing Category Name | ANDA |
| Labeler Name | Hawthorn Pharmaceutical, Inc. |
| Substance Name | CALCIUM ACETATE |
| Strength Number | 667 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] |
